Approval · Notice of Compliance 21952 · 2019
XTORO: Notice of Compliance 21952
Issued March 11, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 21952
- Date
- March 11, 2019
- Company
- Merlion Pharmaceuticals GmbhBerlin, --, Germany
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Labelling Only
- Reason
- Change in Product Ownership Update to the inner labels, the outer label and the package insert
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| XTORO | 02452928 | Approved |
Medicinal ingredients
- FINAFLOXACIN 0.3 PER